ROBIN ROCHOW: Open Payments
NPI 1356590186 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 16 payments from 8 companies in 2025. Trend: 2023 $2,135 · 2024 $1,146 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $91 |
| GlaxoSmithKline, LLC. | 3 | $89 |
| Grifols USA, LLC | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Viatris Specialty LLC | 2 | $43 |
| CSL Behring | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: NUCALA, Prolastin-C Liquid, YUPELRI, TEZSPIRE, Hizentra, FASENRA, EOHILIA, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
